About Mary Crowley Cancer Research
Mary Crowley Cancer Research (MCCR) is an independent, nonprofit oncology research center established in 1997. Founded by Mary C. Crowley, our mission is to expand treatment options for all cancer patients through investigational cellular, gene, and immune therapies.
MCCR has conducted 600+ clinical trials for 6500+ patients in collaboration with 230+ different pharmaceutical partners. MCCR is designed, equipped, and staffed for conducting early phase solid tumor and hematology trials, including performing 80+ first-in-human trials.
FOR MORE INFORMATION, CONTACT:
Alisha Myers, Study Development Manager, and Tina Nghiem, Associate Director, Clinical Trial Development, at firstname.lastname@example.org